AU2018263924A1
|
|
Composition containing cyclodextrin and busulfan
|
AU2017326519A1
|
|
Formulations containing acetaminophen and sulfoalkyl ether cyclodextrin
|
WO2016149685A1
|
|
Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods of using the same
|
AU2015255259A1
|
|
DPI formulation containing sulfoalkyl ether cyclodextrin
|
AU2015255164A1
|
|
Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
|
US2017275388A1
|
|
Fractionated alkylated cyclodextrin compositions and processes for preparing and using the same
|
US2014213650A1
|
|
Injectable Nitrogen Mustard Compositions Comprising a Cyclodextrin Derivative and Methods of Making and Using the Same
|
AU2014200085A1
|
|
Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
|
SG11201503089WA
|
|
Alkylated cyclodextrin compositions and processes for preparing and using the same
|
AU2013201437A1
|
|
DPI formulation containing sulfoalkyl ether cyclodextrin
|
AU2013226073A1
|
|
Alkylated cyclodextrin compositions and processes for preparing and using the same
|
CN104271605A
|
|
Manufacturing process for cyclodextrin derivatives
|
AU2011235943A1
|
|
Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
|
AU2011204957A1
|
|
Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
|
AU2010253905A1
|
|
Injectable melphalan compositions comprising a cyclodextrin derivative and methods of making and using the same
|
KR20120026518A
|
|
Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
|
US2009312724A1
|
|
Nasal and Ophthalmic Delivery of Aqueous Corticosteroid Solutions
|
US2009270348A1
|
|
Sulfoalkyl ether cyclodextrin compositions
|
US2009123540A1
|
|
Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
|
WO2010053487A1
|
|
Composition containing sulfoalkyl ether cyclodextrin and latanoprost
|